At the same time as researchers look for biomarkers to forecast ketamine reaction, clinicians locate on their own with a conundrum: Which patients need to start with IV ketamine, and which with Spravato? And how do The 2 compare head to head in true response to treatment? As I prefer https://abduld448xkn8.bloggosite.com/profile